Concepedia

Ke Li

KL

Statistics

Publications

34

Citations

1.6K

H-Index

25

Active since

2004

Affiliations

Wuhan University(Current)

Hubei Provincial Center for Disease Control and Prevention

Wuhan Donghu University

Soochow University

Renmin Hospital of Wuhan University

Ke Li is an author at Wuhan University specializing in life sciences, oncology, and nanomedicine.

ORCID

Publications per year

2004–2023

34

Publications

34

Dendritic cell-mediated delivery of doxorubicin-polyglycerol-nanodiamond composites elicits enhanced anti-cancer immune response in glioblastoma

Tong‐Fei Li, Ke Li, Quan Zhang et al. · Biomaterials · 2018 · 127 citations

, , +16

Loss of immunity-supported senescence enhances susceptibility to hepatocellular carcinogenesis and progression in Toll-like receptor 2-deficient mice

Heng Lin, Jun Yan, Ziyan Wang et al. · Hepatology · 2012 · 101 citations · Full text

, , +17

Harnessing the cross-talk between tumor cells and tumor-associated macrophages with a nano-drug for modulation of glioblastoma immune microenvironment

Tong‐Fei Li, Ke Li, Chao Wang et al. · Journal of Controlled Release · 2017 · 94 citations

, , +16

Stimulation-responsive mucoadhesive probiotics for inflammatory bowel disease treatment by scavenging reactive oxygen species and regulating gut microbiota

Qian‐Xiao Huang, Jun‐Long Liang, Chi-Hui Yang et al. · Biomaterials · 2023 · 87 citations

, , +17

Doxorubicin-polyglycerol-nanodiamond composites stimulate glioblastoma cell immunogenicity through activation of autophagy

Tong‐Fei Li, Yong‐Hong Xu, Ke Li et al. · Acta Biomaterialia · 2019 · 82 citations

, , +14

1–5 of 34